Calyxt, Inc. (CLXT) has 55 open-market insider trades by 16 insiders since 2017. The most active filer is Daniel F. Voytas, CSO.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Cellectis S.A. | 10% Owner | — | 1 | $2.5M | 2020-10-16 |
| Daniel F. Voytas | CSO | — | 21 | $1.7M | 2021-01-04 |
| Alain Godard | Dir | — | 6 | $1.2M | 2018-06-21 |
| Yves J. Ribeill | Dir | — | 5 | $911K | 2022-09-19 |
| Manoj Sahoo | CCO | — | 3 | $500K | 2019-07-01 |
| Bryan W.j. Corkal | CFO | — | 2 | $478K | 2018-06-15 |
| Michel Arbadji | Dir | — | 3 | $291K | 2018-06-20 |
| Federico A. Tripodi | CEO | — | 1 | $287K | 2018-06-15 |
| James Blome | CEO | — | 3 | $118K | 2020-12-31 |
| Andre Choulika | Dir | — | 2 | $66K | 2020-07-01 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Yves J. Ribeill | Director | Sell | $7K | 2022-09-19 |
| Yves J. Ribeill | Director | Sell | $21K | 2022-03-21 |
| Michael A. Carr | President | Buy | $40K | 2021-08-30 |
| William Koschak | CFO | Buy | $64K | 2021-08-19 |
| Christopher J. Neugent | Director | Buy | $59K | 2021-05-12 |
| Daniel F. Voytas | Chief Science Officer | Sell | $10K | 2021-01-04 |
Companies that share insiders with CLXT, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| James Blome | CEO | Sell | $17K | 2020-12-31 |
| Daniel F. Voytas | Chief Science Officer | Sell | $24K | 2020-12-18 |
| Travis Frey | CTO | Buy | $569 | 2020-12-01 |
| Travis Frey | CTO | Buy | $489 | 2020-11-02 |
| Travis Frey | CTO | Buy | $821 | 2020-10-01 |
| James Blome | CEO | Sell | $23K | 2020-09-30 |
| Philippe Dumont | Director | Buy | $18K | 2020-09-10 |
| Travis Frey | CTO | Buy | $812 | 2020-09-01 |
| Philippe Dumont | Director | Buy | $15K | 2020-08-14 |